首页> Diabetes, obesity & metabolism> Two-tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross-sectional study.

Two-tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross-sectional study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Alessandro,Mantovani

第一单位： Metabolic Diseases Research Unit, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella, Italy.;Department of Medicine, University of Verona, Verona, Italy.

作者： Alessandro,Mantovani ^[1] ; Rosa,Lombardi ^[2] ; Andrea,Dalbeni ^[3] ; Riccardo,Morandin ^[4] ; Maria Giovanna,Lando ^[4] ; Veronica,Fiorio ^[4] ; Nicoletta,Rolli ^[4] ; Matteo,Forti ^[4] ; Dario,Messetti ^[4] ; Mirko,Zoncape ^[3] ; Ilaria,Milani ^[5] ; Maria Eugenia,Parrotta ^[6] ; Danila,Capoccia ^[5] ; Valeria,Guglielmi ^[6] ; Frida,Leonetti ^[5] ; Paolo,Sbraccia ^[6] ; Anna Ludovica,Fracanzani ^[2] ; Giovanni,Targher ^[1]

作者单位： Metabolic Diseases Research Unit, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella, Italy.;Department of Medicine, University of Verona, Verona, Italy. ^[1] Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.;Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. ^[2] Section of General Medicine C and Liver Unit, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy. ^[3] Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy. ^[4] Department of Medico-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, University of Rome La Sapienza, Latina, Italy. ^[5] Department of Systems Medicine, University of Rome Tor Vergata, Obesity Medical Center, University Hospital Policlinico Tor Vergata, Rome, Italy. ^[6]

关键词 CAP FIB4 Fibroscan MASLD T2DM diabetes mellitus fibrosis hepatic steatosis metabolic dysfunction‐associated steatotic liver disease type 2 diabetes